Xinhua Lu | Neurosurgery | Best Researcher Award

Dr. Xinhua Lu | Neurosurgery | Best Researcher Award

Attending Doctor from Foresea Life Insurance Guangzhou General Hospital, China

Xinhua Lu is an emerging biomedical researcher specializing in the molecular mechanisms of nerve regeneration and cell biology. Based in Guangzhou, China, Lu has developed a strong academic and research portfolio through rigorous education and hands-on experience in clinical and laboratory settings. His core focus is centered around the regulatory functions of microRNAs, particularly microRNA-21, in Schwann cell behavior following peripheral nerve injury. Through various research projects, Lu has contributed to the understanding of autophagy, apoptosis, and cellular regeneration pathways, with an emphasis on translational applications in neuroscience and dermatology. His collaborative work has led to co-authorship in several high-impact journals, reflecting a growing reputation in biomedical research. Lu’s research demonstrates interdisciplinary knowledge spanning molecular biology, neurophysiology, and clinical pathology. As a core member of research projects at Zhongshan University, he has played a significant role in advancing discoveries that may lead to novel treatments for nerve damage and degenerative conditions. Known for his dedication, curiosity, and collaborative spirit, Xinhua Lu continues to make meaningful contributions to his field and holds promising potential as a future leader in medical research. His academic integrity and persistence mark him as a valuable member of the scientific community.

Professional Profile

Education

Xinhua Lu has pursued an educational path strongly aligned with clinical and biomedical sciences, beginning with a Bachelor of Science degree in Clinical Medicine from Kunming Medical University, China, completed between September 2008 and July 2013. This foundational education equipped him with core competencies in clinical diagnostics, human anatomy, pharmacology, and patient care. Building on this, Lu further specialized by enrolling in the Master of Science program in Surgery at Zhongshan University in Guangzhou, where he studied from August 2013 to June 2016. During his postgraduate studies, he focused on surgical techniques, clinical interventions, and molecular mechanisms involved in tissue repair. His graduate education laid the groundwork for his research into peripheral nerve injuries and the role of microRNAs in regenerative medicine. Throughout both degree programs, Lu demonstrated strong academic performance and a growing interest in laboratory-based investigations. His thesis work and academic projects were aligned with his current research interests in nerve cell biology, which later transitioned into collaborative and independently led research initiatives. This well-rounded education reflects both theoretical grounding and practical proficiency, qualifying him for research-intensive roles in clinical and academic settings alike.

Professional Experience

Xinhua Lu’s professional experience is marked by his active engagement in biomedical research, particularly focusing on nerve injury and repair. He began his research career as a graduate student at Zhongshan University, where he participated in a project investigating the role of microRNA-21 in Schwann cell behavior post-peripheral nerve injury. This work was not only foundational to his academic development but also instrumental in launching his specialization in neuroregeneration. Between 2016 and 2020, Lu continued his professional trajectory as a core member of a major research project studying the regulatory mechanism of microRNA-21 in Schwann cell autophagy. In this role, he contributed to both experimental design and data analysis, helping elucidate how microRNA-21 modulates cellular processes critical to nerve healing. His involvement in scholarly writing and data interpretation led to multiple co-authored publications in reputable international journals. These experiences positioned Lu as a competent and collaborative researcher capable of handling complex molecular biology projects. In addition to research, he has likely been involved in manuscript preparation and peer communication, showcasing skills essential for academic dissemination. Overall, his professional journey underscores his growing influence in the field and dedication to biomedical advancement.

Research Interest

Xinhua Lu’s primary research interests lie at the intersection of molecular biology and clinical neuroscience, with a specific focus on peripheral nerve injury and repair mechanisms. His fascination with how the body recovers from nerve damage has led him to study Schwann cells, which are critical players in nerve regeneration. A major area of his investigation is the role of microRNA-21 (miR-21) in regulating Schwann cell activity, including its involvement in autophagy, apoptosis inhibition, and proliferation. He is particularly interested in how miR-21 modulates these processes to promote axonal regeneration and functional nerve recovery. In recent years, Lu has expanded his research scope to include broader mechanisms of cell signaling and immune responses, particularly within dermatological and pathological contexts. His work has also explored the cGAS-STING pathway and CD47 signaling, demonstrating a keen interest in understanding immune-mediated responses and cellular aging. His research contributes to both theoretical understanding and the potential development of targeted therapies in neurodegenerative diseases, skin conditions, and injury rehabilitation. By bridging the gap between molecular insight and clinical application, Lu’s research continues to explore complex cellular dynamics with promising translational outcomes.

Research Skills

Xinhua Lu has developed a well-rounded set of research skills that span molecular biology techniques, project coordination, and academic publishing. His laboratory proficiency includes working with cultured Schwann cells, conducting apoptosis and autophagy assays, and utilizing molecular markers to trace cellular changes in response to microRNA modulation. These skills are particularly evident in his work on the mechanisms of miR-21 in nerve regeneration. Lu is adept in experimental design and analysis, often contributing to the validation of hypotheses through controlled in vitro experiments. In addition, he demonstrates competence in interpreting gene expression patterns and cellular signaling pathways. Outside the lab, Lu is skilled in scholarly communication and has co-authored multiple peer-reviewed articles, reflecting his familiarity with the structure, style, and rigor of academic publishing. His technical proficiency also extends to common productivity software such as Microsoft Office and Photoshop, although there is room for advancement in bioinformatics tools and statistical programming. Moreover, his ability to collaborate on multi-year research projects highlights his organizational skills and teamwork. Overall, Lu’s methodological, analytical, and communication abilities position him as a capable biomedical researcher with a solid foundation for continued academic success.

Awards and Honors

While specific awards and honors are not explicitly listed in Xinhua Lu’s profile, his co-authorship on several high-impact, peer-reviewed publications serves as a form of academic recognition in its own right. Publishing in journals such as Brain Pathology, Journal of Cosmetic Dermatology, Journal of Dermatological Science, and RNA Biology reflects the scholarly value and relevance of his research. These publications are typically peer-reviewed by experts and signify rigorous vetting, which in itself is an indicator of research excellence. Being named as a core member in significant research projects at Zhongshan University further underlines his trusted role within the academic research team. This kind of professional trust often correlates with internal academic awards, project-based recognition, or institutional support, even if not explicitly detailed in his CV. Given the caliber of his co-authors and institutions, it is likely that Lu has been involved in competitive grant-funded projects or has received commendation for his academic contributions. Although further documentation of honors such as fellowships, travel grants, or presentation awards would enhance this section, his current achievements provide solid evidence of emerging recognition in the biomedical research community.

Conclusion

Xinhua Lu presents a compelling academic and research profile, characterized by dedication to the study of nerve regeneration and molecular cell biology. With formal education in clinical medicine and surgery, and multiple years of experience in laboratory-based biomedical research, he brings both theoretical knowledge and hands-on expertise to his field. His focused work on microRNA-21 and Schwann cell dynamics demonstrates not only technical ability but also scientific curiosity aimed at solving real-world clinical problems. Through participation in multi-year research projects and peer-reviewed publications, he has proven himself a capable and collaborative scholar. While there is still room to strengthen his portfolio—particularly through greater international exposure, leadership in publications, and diversification of technical skills—Lu’s current achievements position him as a strong candidate for recognition and further academic development. His contributions enrich our understanding of nerve injury mechanisms and open potential pathways for future medical therapies. As he continues his research journey, Xinhua Lu is poised to make a meaningful and lasting impact in biomedical sciences.

Publications Top Notes

  • Title: Elevated CD47 Expression Impairs Elimination of Photoaged Fibroblasts by Macrophages and Serves as a Potential Biomarker for Photoaging

  • Authors: Xu Xinya, Lu Xinhua, Chen Xinling, Yao Amin, Lai Wei

  • Year: 2025

Berta Mosleh | Thoracic Surgery | Best Researcher Award

Dr. Berta Mosleh | Thoracic Surgery | Best Researcher Award

Department of Thoracic Surgery from Medical University of Vienna, Austria.

Berta Mosleh, MD, MSc, is a dedicated medical professional with a strong background in thoracic surgery and oncological research. She is currently pursuing a Doctoral Programme in Applied Medical Science at the Medical University of Vienna, focusing on inflammatory proteins and growth factors as biomarkers in malignant pleural mesothelioma. With a medical degree from the Medical University of Vienna and a master’s in economics from Corvinus University of Budapest, she combines clinical expertise with analytical skills. Dr. Mosleh has extensive experience in thoracic surgery, lung cancer research, and minimally invasive surgical procedures. She has contributed significantly to medical literature, with multiple peer-reviewed publications exploring the molecular and clinical aspects of thoracic malignancies. Through her work at Vienna General Hospital and involvement in various research programs, she has gained expertise in interventional bronchoscopy, cytoreductive surgery, and hyperthermic intrathoracic chemotherapy. Her research interests include oncological biomarkers, immunotherapy, and sex-based differences in lung cancer susceptibility. Dr. Mosleh’s commitment to advancing thoracic oncology has earned her recognition in the medical community. With a passion for research and innovation, she strives to enhance treatment strategies and patient outcomes in thoracic malignancies.

Professional Profile

Education

Dr. Berta Mosleh has a multidisciplinary academic background spanning medicine and economics. She is currently enrolled in the Doctoral Programme of Applied Medical Science at the Medical University of Vienna, where she is researching biomarkers for malignant pleural mesothelioma. She obtained her Doctor of Medicine (MD) degree from the Medical University of Vienna in 2019, equipping her with extensive clinical knowledge and surgical expertise. Before transitioning into medicine, Dr. Mosleh earned a Master’s degree in Economics from Corvinus University of Budapest, specializing in Business Administration and Financial Accounting. This diverse academic foundation provides her with a unique perspective on healthcare management and medical research. Throughout her education, she has engaged in numerous internships and research projects, solidifying her expertise in thoracic oncology, minimally invasive surgery, and pulmonary disease management. Her dedication to academic excellence is evident in her ongoing pursuit of medical advancements through research and clinical practice.

Professional Experience

Dr. Berta Mosleh has accumulated a wealth of experience in thoracic surgery and research. Since October 2019, she has been a surgical resident at Vienna General Hospital’s Department of Thoracic Surgery, where she actively participates in the “Thoracic Malignancies Research Program” and the “Malignant Pleural Mesothelioma Treatment and Research Program.” She previously served as a surgical and research intern at the same institution, gaining hands-on experience in minimally invasive procedures and oncological treatments. Dr. Mosleh has also contributed to research in general surgery and pulmonology, undertaking internships in internal medicine, orthopedic surgery, and reconstructive surgery. Her early career included positions in business consulting as a risk advisor at Ernst & Young and a financial auditor at Deloitte. This diverse professional background complements her medical expertise, enhancing her ability to analyze complex healthcare data and optimize clinical decision-making. Her commitment to thoracic oncology and continuous learning makes her an asset in both clinical and research settings.

Research Interests

Dr. Berta Mosleh’s research interests center on thoracic oncology, with a focus on malignant pleural mesothelioma, lung cancer, and pleural disease. She is particularly interested in identifying biomarkers for early diagnosis and treatment response in thoracic malignancies. Her research explores inflammatory proteins, growth factors, and immune checkpoint inhibitors to improve therapeutic strategies. Dr. Mosleh also investigates sex-based differences in lung cancer susceptibility and genetic alterations, aiming to refine personalized treatment approaches. Another key area of her research is the role of immunotherapy and targeted treatments in lung cancer and mesothelioma. Her work extends to the assessment of PD-1 and PD-L1 expression in lung cancer, evaluating their impact on disease progression and patient survival. Through her involvement in multiple studies, she aims to bridge the gap between experimental findings and clinical applications, ultimately improving patient care in thoracic oncology.

Research Skills

Dr. Berta Mosleh possesses a strong skill set in both clinical and laboratory research. She has expertise in biomarker analysis, molecular diagnostics, and immunohistochemistry, allowing her to study disease mechanisms at a cellular level. Her proficiency in clinical trial design and statistical analysis enables her to conduct high-quality medical research. She is skilled in various thoracic surgery techniques, including minimally invasive procedures, interventional bronchoscopy, and cytoreductive surgery. Dr. Mosleh is also adept at medical writing and has authored several peer-reviewed publications. Her ability to collaborate with interdisciplinary teams has been instrumental in advancing research projects. Additionally, her background in economics and data analysis enhances her capacity to assess healthcare trends and optimize treatment strategies. With a strong foundation in both clinical and translational research, she continues to contribute to advancements in thoracic oncology and surgical innovation.

Awards and Honors

Dr. Berta Mosleh has received recognition for her contributions to thoracic surgery and cancer research. Her work in identifying biomarkers for malignant pleural mesothelioma has been acknowledged in academic conferences and peer-reviewed journals. She has been invited to present her findings at prestigious medical symposiums, such as the ÖGP | OGTC Jahrestagung and Cancer Update CCC Vienna. Her research on sex-based differences in lung cancer susceptibility has gained attention within the scientific community. Additionally, her role in evaluating PD-1 and PD-L1 expression in lung cancer has contributed to understanding tumor immunology. Dr. Mosleh’s dedication to medical innovation and patient-centered research has earned her respect among colleagues and mentors. As she continues her research in thoracic oncology, she remains committed to furthering advancements in cancer diagnosis and treatment.

Conclusion

Dr. Berta Mosleh is a highly accomplished thoracic surgeon and researcher, dedicated to advancing the understanding and treatment of lung cancer and malignant pleural mesothelioma. With a solid academic foundation, extensive surgical experience, and a passion for oncological research, she has made significant contributions to the medical field. Her expertise in biomarker discovery, immunotherapy, and minimally invasive procedures positions her at the forefront of thoracic oncology. Through her commitment to scientific research and patient care, Dr. Mosleh continues to drive innovation in cancer treatment. Her ability to integrate clinical practice with research findings ensures that her work has a tangible impact on improving patient outcomes. As she progresses in her career, she remains dedicated to enhancing diagnostic tools, refining therapeutic strategies, and mentoring future medical professionals.

Publications Top Notes

  1. Title: Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s

    • Authors: B.O. Mosleh, Berta O.; P. Sarova, Pavla; S. Zehetmayer, Sonja; M.A. Hoda, Mir Alireza; D.R. Gompelmann, Daniela Rosa
    • Year: 2025
  2. Title: The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung disease

    • Authors: K. Nakanishi, Keita; T. Schweiger, Thomas; S. Schwarz, Stefan; T.F. Chen-Yoshikawa, Toyofumi Fengshi; K. Hoetzenecker, Konrad
    • Year: 2025
    • Citations: 1